AI assistant
Torrent Pharmaceuticals Ltd. — Call Transcript 2023
Oct 26, 2023
61979_rns_2023-10-26_4cc93a73-cc2f-4b14-8674-6754f7f0da58.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [95 x 30] intentionally omitted <==
26[th] October, 2023
The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)
Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30[th] September, 2023
In continuation of our letter dated 16-Oct-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30[th] September, 2023, has been placed on the Company’s website at https://www.torrentpharma.com/pdf/investors/TorrentPharma-Earnings-23Oct-2023.pdf
Kindly take note of the above.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN Digitally signed by CHINTAN MAHESHKUM MAHESHKUMAR TRIVEDI Date: 2023.10.26 AR TRIVEDI 09:40:17 +05'30' CHINTAN M. TRIVEDI COMPANY SECRETARY
___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED
CIN: L24230GJ1972PLC002126
Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : [email protected]